Previous Statements by MRK
» Merck & Co.'s CEO Discusses Q4 2011 Results - Earnings Call Transcript
» Merck & Co. Inc. - Special Call
» Merck & Co.'s CEO Discusses Q3 2011 Results - Earnings Call Transcript
Sarepta Therapeutics, Paratek Pharmaceuticals and PDL BioPharma were among the biotech stock movers in premarket trading on Monday.
Doug Kass shares his thoughts on Apple, Allergan and Western Digital.